118 related articles for article (PubMed ID: 11354396)
1. Pharmaceutical prices: the debate continues.
Coons SJ
Clin Ther; 2001 Apr; 23(4):628. PubMed ID: 11354396
[No Abstract] [Full Text] [Related]
2. To Address Drug Affordability, Grab the Low-hanging Fruit.
Mello MM; Riley T
JAMA; 2021 Apr; 325(16):1599-1600. PubMed ID: 33904881
[No Abstract] [Full Text] [Related]
3. Prescription drug prices in Canada.
Gross D
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
[No Abstract] [Full Text] [Related]
4. New rules for US drug reimbursement.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
[No Abstract] [Full Text] [Related]
5. Retail drug prices found higher in U.S. than abroad.
Mahaney FX
J Natl Cancer Inst; 1994 Sep; 86(18):1377-8. PubMed ID: 8072028
[No Abstract] [Full Text] [Related]
6. Bid to limit prices on drugs using 'public' discoveries.
Wadman M
Nature; 1998 May; 393(6683):297. PubMed ID: 9620788
[No Abstract] [Full Text] [Related]
7. Sanofi vows to limit price hikes- but will it make much difference?
Kacik A
Mod Healthc; 2017 May; 47(20):12. PubMed ID: 30496647
[TBL] [Abstract][Full Text] [Related]
8. [Effect of Royal Decree-Law 16/2012 on consumption of drugs excluded from public coverage in Navarre (Spain)].
Aldaz P; Escalada D; Martínez-Monreal B; Azparren A; Ursúa ME
Gac Sanit; 2015; 29(1):77-8. PubMed ID: 25200375
[No Abstract] [Full Text] [Related]
9. Engineering new strategies in specialty pharmacy management.
Edlin M
AHIP Cover; 2004; 45(5):34-9. PubMed ID: 15499743
[No Abstract] [Full Text] [Related]
10. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
Moken MC
Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
[No Abstract] [Full Text] [Related]
11. Maximum allowable cost: can the government control drug costs?
Smith MI; Wertheimer AI
J Health Polit Policy Law; 1979; 4(2):155-75. PubMed ID: 385712
[TBL] [Abstract][Full Text] [Related]
12. The maze of Medicare.
Health News; 2004 Feb; 10(2):3. PubMed ID: 15032149
[No Abstract] [Full Text] [Related]
13. United States prescription drug crisis. Reimportation of Canadian prescription drugs is not the answer.
Martin J
J Leg Med; 2006 Dec; 27(4):477-92. PubMed ID: 17162683
[No Abstract] [Full Text] [Related]
14. Drug price hikes and shortages have similar roots, experts say.
Traynor K
Am J Health Syst Pharm; 2016 Feb; 73(3):98-9. PubMed ID: 26796898
[No Abstract] [Full Text] [Related]
15. Increase competition to stabilize drug prices.
Miller HI
Science; 2001 Jul; 293(5528):213-4. PubMed ID: 11452976
[No Abstract] [Full Text] [Related]
16. Medicare and drug pricing.
Iglehart JK
N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
[No Abstract] [Full Text] [Related]
17. Revised drug policy.
Shelat AJ
J Indian Med Assoc; 1995 Mar; 93(3):117-8. PubMed ID: 8522818
[No Abstract] [Full Text] [Related]
18. Medicare Part D: who wins, who loses?
Am Fam Physician; 2006 Feb; 73(3):401. PubMed ID: 16477886
[TBL] [Abstract][Full Text] [Related]
19. Prescription drug spending: contribution to health care spending and cost containment strategies.
Rivers PA; Hall NG; Frimpong J
J Health Care Finance; 2006; 32(3):8-19. PubMed ID: 18975728
[TBL] [Abstract][Full Text] [Related]
20. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
Martikainen J; Kivi I; Linnosmaa I
Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
